LD-2 disclosure · 2nd Quarter - Report
BRAEBURN PHARMACEUTICALS, INC.
Client
- Name
- BRAEBURN PHARMACEUTICALS, INC.
- Description
- pharmaceutical company
- Location
- New Jersey · United States of America
Registrant
- Description
- government affairs
- Location
- Annapolis, Maryland, United States of America
Lobbying activities
2 issuesHealth Issues
Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; Patient access to practitioner-administered therapies; MAT availability in federal prisons
LobbyistsVALERIE HENRY · JAMES DERDERIAN · JOSEPH RACHINSKY jr · mr BRYAN WILLIAM WELLS · AISLING MCDONOUGH · KEVIN DAWSON
Covered position (VALERIE HENRY): Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
Covered position (JAMES DERDERIAN): Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
Covered position (mr BRYAN WILLIAM WELLS): Policy Advisor, Senator Pat Roberts
Covered position (AISLING MCDONOUGH): Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
Covered position (KEVIN DAWSON): Chief of Staff, Congressman Mike Kelly; Health Policy Advisor, Senator Bill Cassidy; Professional Staff Member, Senate Committee on the Budget
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Pilot programs related to Medicaid pricing
LobbyistsVALERIE HENRY · JAMES DERDERIAN · JOSEPH RACHINSKY jr · mr BRYAN WILLIAM WELLS · AISLING MCDONOUGH · KEVIN DAWSON